Dark
Light
System
Security
KALVISTA PHARMACEUTICALS INC
KALVISTA PHARMACEUTICALS INC. Institutional holdings reported to the SEC.

Institutional Holders (2017Q1)
Portfolio Summary: 20 Institutional holders with a total value of $59,163,000.
#
Manager Name
Shares
Value ($)
%
Options
Notes
1 DEUTSCHE BANK AG\ 5 0 0.00%
2 ROYAL BANK OF CANADA 1 0 0.00%
3 MORGAN STANLEY 200 1,000 0.00%
4 MANUFACTURERS LIFE INSURANCE COMPANY, THE 310 3,000 0.01%
5 Tower Research Capital LLC (TRC) 705 6,000 0.01%
6 UBS Group AG 2,307 18,000 0.03%
7 BlackRock Finance, Inc. 3,418 27,000 0.05%
8 FIRST QUADRANT LLC/CA 10,850 85,000 0.14%
9 A.R.T. Advisors, LLC 11,116 86,000 0.15%
10 Alyeska Investment Group, L.P. 11,316 88,000 0.15%
11 BOOTHBAY FUND MANAGEMENT, LLC 21,665 169,000 0.29%
12 EVENTIDE ASSET MANAGEMENT, LLC 98,100 766,000 1.29%
13 VANGUARD GROUP INC 180,772 1,412,000 2.39%
14 VHCP MANAGEMENT II, LLC 221,651 1,635,000 2.76%
15 VIVO CAPITAL, LLC 300,325 2,346,000 3.97%
16 INTERNATIONAL BIOTECHNOLOGY TRUST PLC 322,436 2,518,000 4.26%
17 INTERWEST VENTURE MANAGEMENT CO 329,942 2,577,000 4.36%
18 RA CAPITAL MANAGEMENT, L.P. 591,070 4,616,000 7.80%
19 SV Health Investors, LLC 2,579,490 20,146,000 34.05%
20 Novo Holdings A/S 2,901,927 22,664,000 38.31%

From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.